Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
Office of Biotechnology Products, CDER, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
Cell Rep. 2020 Feb 4;30(5):1292-1299.e3. doi: 10.1016/j.celrep.2019.12.099.
Human Fc receptor-like 3 (FCRL3) is an orphan receptor expressed by lymphocytes, including regulatory T cells. FCRL3 is implicated in several autoimmune diseases; however, its function on regulatory T cells is unknown. We discovered that FCRL3 stimulation of regulatory T cells inhibited their suppressive function. Moreover, FCRL3 stimulation induced IL-17, IL-26, and IFNγ production and promoted expression of the Th17-defining transcription factor RORγt without affecting FOXP3 expression. We suggest that FCRL3 engagement mediates a transition of regulatory T cells to a pro-inflammatory Th17-like phenotype. In addition, we identified secretory IgA as a specific FCRL3 ligand. Secretory IgA could serve as an environmental cue for mucosal breaches and locally drive regulatory T cell plasticity to help control infection. Our findings define a mechanism that explains the recognized association of FCRL3 with autoimmune diseases. Targeting FCRL3 to modulate regulatory T cell activity could be exploited to treat both malignancies and autoimmune diseases.
人类 Fc 受体样 3(FCRL3)是一种表达于淋巴细胞的孤儿受体,包括调节性 T 细胞。FCRL3 与多种自身免疫性疾病有关;然而,其在调节性 T 细胞上的功能尚不清楚。我们发现 FCRL3 刺激调节性 T 细胞抑制其抑制功能。此外,FCRL3 刺激诱导了 IL-17、IL-26 和 IFNγ 的产生,并促进了 Th17 定义转录因子 RORγt 的表达,而不影响 FOXP3 的表达。我们认为,FCRL3 的结合介导了调节性 T 细胞向促炎 Th17 样表型的转变。此外,我们鉴定出分泌型 IgA 是 FCRL3 的特异性配体。分泌型 IgA 可作为黏膜破裂的环境线索,并在局部驱动调节性 T 细胞可塑性,以帮助控制感染。我们的发现定义了一种解释 FCRL3 与自身免疫性疾病相关的机制。靶向 FCRL3 以调节调节性 T 细胞的活性可能被用于治疗恶性肿瘤和自身免疫性疾病。